Differential alteration of the nigrostriatal dopaminergic system in Wilson's disease investigated with [123I]β-CIT and high-resolution SPET

European Journal of Nuclear Medicine

Volumn 28, Issue 11, 2001, Pages 1656-1663

  Barthel, Henryk ^a,b   Sorger, Dietlind ^a   Kühn, Hans Jürgen ^a   Wagner, Armin ^a   Kluge, Regine ^a   Hermann, Wieland ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

123I CIT; Dopamine transporter; SPET; Wilson's disease

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER I 123; DOPAMINE TRANSPORTER; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DISSOCIATION; DOPAMINERGIC SYSTEM; DRUG BINDING; FEMALE; HUMAN; HYPERKINESIA; MALE; NEUROLOGIC DISEASE; NIGRONEOSTRIATAL SYSTEM; PARKINSONISM; PUTAMEN; SCLEROSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WILSON DISEASE;

ADULT; BRAIN DISEASES; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; IODINE RADIOISOTOPES; LIVER DISEASES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; OBSERVER VARIATION; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034763074     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590100623     Document Type: Article

References (44)

1. Progressive lenticular degeneration: A familial nervous disease associated with cirrhosis of the liver
2. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene
3. Western blot analysis in patients with hypocaeruloplasminaemia
4. Kayser-Fleischer ring in a patient with Wilson's disease
5. Wilson's disease: MRI with clinical correlation
6. Wilson's disease in patients presenting with liver disease: A diagnostic challenge
7. Neurological and neuropsychiatric spectrum of Wilson's disease: A prospective study of 45 cases
8. Wilson's disease: Evidence of subgroups derived from clinical findings and brain lesions
9. Neuropsychiatric correlates and treatment of lenticulostriatal diseases
10. Immunohistochemical determination of the Wilson copper-transporting P-type ATPase in the brain tissue of the rat
11. Treatment of Wilson's disease with L-dopa after failure with penicillamine
12. Favorable results with an association of L-dopa and amantadine added to penicillamine in the treatment of Wilson's disease
13. Mid-brain pathology of Wilson's disease: MRI analysis of three cases
14. Wilson's disease: Magnetic resonance imaging (MRI) with clinical correletions in 16 cases
15. 123I-IBZM: Initial experience in controls and patients with Parkinson's syndrome and Wilson's disease
16. Neurological impairment and recovery in Wilson's disease: Evidence from PET and MRI
17. 123I-iodobenzamide binding
18. The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography
19. 123I]-β-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease
20. Neurological Wilson's disease studies with magnetic resonance imaging and with positron emission tomography using dopaminergic markers
21. 123I]β-CIT binding to dopamine transporters in healthy human subjects
22. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons
23. Single photon emission computed tomographic imaging demonstrates loss of striatal monoamine transporters in Parkinson's disease
24. 123I]β-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission computed tomography
25. 123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder
26. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour
27. 64Cu
28. Wilsonsche erkrankung in der DDR: Rückblick und ausblick - Eine bilanz
29. Simplified multidose preparation of iodine-123-beta-CIT: A marker for dopamine transporters
30. Brain perfusion SPECT using annular single crystal camera: Initial clinical experience
31. 123I]beta-CIT. Binding kinetics in the human brain
32. Age-related decline in striatal dopamine transporter binding with iodine-123-β-CIT SPECT
33. Wilson's disease: Modification by L-DOPA
34. H714Q mutation in Wilson disease is associated with late, neurological presentation
35. Very high frequency of the His1069Gln mutation in Polish Wilson disease patients
36. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism
37. 123I]β-CIT striatal up-take correlates with symptom severity in Parkinson's disease
38. Magnetic resonance imaging and proton MR spectroscopy in Wilson's disease
39. Cranial MR imaging in Wilson's disease
40. Multimodal SPECT and MRT imaging data analysis for an improvement in the diagnosis of idiopathic Parkinson's syndrome
41. Initial and follow-up brain MRI findings and correlation with the clinical course in Wilson's disease
42. Cranial MR findings in Wilson's disease